Aprea Therapeutics, Inc. Other Nonoperating Income (Expense)
Aprea Therapeutics, Inc. (APRE) reported Other Nonoperating Income (Expense) of $440.88 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-12
- Aprea Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $440.88K, a 196.08% increase year-over-year.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $142.50K, a 6.82% decline year-over-year.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $187.46K, a 43.41% decline year-over-year.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $144.98K, a 53.72% decline year-over-year.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was $634.27K, a 53.40% decline from fiscal 2024.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was $1.36M, a 14.83% increase from fiscal 2023.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was $1.19M, a 62.31% increase from fiscal 2022.
- Aprea Therapeutics, Inc. other nonoperating income (expense) for fiscal 2022 was $730.20K, a 128.87% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $440.88K 10-Q · filed 2026-08-12 | $583.37K 10-Q · filed 2026-08-12 | $770.83K derived: sum of 3 quarters · filed 2026-08-12 | $915.81K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $142.50K 10-Q · filed 2026-05-13 | $329.96K derived: sum of 2 quarters · filed 2026-05-13 | $474.94K derived: sum of 3 quarters · filed 2026-05-13 | $623.84K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $187.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $332.44K derived: sum of 2 quarters · filed 2026-03-16 | $481.34K derived: sum of 3 quarters · filed 2026-08-12 | $634.27K 10-K · filed 2026-03-16 |
| 2025-09-30 | $144.98K 10-Q · filed 2025-11-12 | $293.88K derived: sum of 2 quarters · filed 2026-08-12 | $446.80K 10-Q · filed 2025-11-12 | $778.05K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $148.90K 10-Q · filed 2026-08-12 | $301.83K 10-Q · filed 2026-08-12 | $633.07K derived: sum of 3 quarters · filed 2026-08-12 | $946.32K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $152.92K 10-Q · filed 2026-05-13 | $484.17K derived: sum of 2 quarters · filed 2026-05-13 | $797.42K derived: sum of 3 quarters · filed 2026-05-13 | $1.17M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $331.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $644.49K derived: sum of 2 quarters · filed 2026-03-16 | $1.02M derived: sum of 3 quarters · filed 2026-03-16 | $1.36M 10-K · filed 2026-03-16 |
| 2024-09-30 | $313.25K 10-Q · filed 2025-11-12 | $690.12K derived: sum of 2 quarters · filed 2025-11-12 | $1.03M 10-Q · filed 2025-11-12 | $1.26M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $376.87K 10-Q · filed 2025-08-12 | $716.45K 10-Q · filed 2025-08-12 | $948.13K derived: sum of 3 quarters · filed 2025-08-12 | $1.27M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $339.58K 10-Q · filed 2025-05-14 | $571.25K derived: sum of 2 quarters · filed 2025-05-14 | $889.59K derived: sum of 3 quarters · filed 2025-05-14 | $1.28M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $231.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $550.01K derived: sum of 2 quarters · filed 2025-03-25 | $942.59K derived: sum of 3 quarters · filed 2025-03-25 | $1.19M 10-K · filed 2025-03-25 |
| 2023-09-30 | $318.33K 10-Q · filed 2024-11-07 | $710.92K derived: sum of 2 quarters · filed 2024-11-07 | $953.53K 10-Q · filed 2024-11-07 | $1.16M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $392.58K 10-Q · filed 2024-08-12 | $635.20K 10-Q · filed 2024-08-12 | $844.68K derived: sum of 3 quarters · filed 2024-08-12 | $1.02M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $242.61K 10-Q · filed 2024-05-14 | $452.10K derived: sum of 2 quarters · filed 2024-05-14 | $627.58K derived: sum of 3 quarters · filed 2024-05-14 | $834.63K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $209.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $384.96K derived: sum of 2 quarters · filed 2024-03-26 | $592.02K derived: sum of 3 quarters · filed 2024-03-26 | $730.20K 10-K · filed 2024-03-26 |
| 2022-09-30 | $175.48K 10-Q · filed 2023-11-09 | $382.53K derived: sum of 2 quarters · filed 2023-11-09 | $520.72K 10-Q · filed 2023-11-09 | $594.21K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $207.06K 10-Q · filed 2023-08-10 | $345.24K 10-Q · filed 2023-08-10 | $418.73K derived: sum of 3 quarters · filed 2024-03-26 | $396.79K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $138.18K 10-Q · filed 2023-05-15 | $211.68K derived: sum of 2 quarters · filed 2024-03-26 | $189.74K derived: sum of 3 quarters · filed 2024-03-26 | -$63.69K derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $73.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $51.55K derived: sum of 2 quarters · filed 2024-03-26 | -$201.88K derived: sum of 3 quarters · filed 2024-03-26 | $319.05K 10-K · filed 2024-03-26 |
| 2021-09-30 | -$21.94K 10-Q · filed 2022-11-09 | -$275.37K derived: sum of 2 quarters · filed 2022-11-09 | $245.56K 10-Q · filed 2022-11-09 | -$923.59K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$253.43K 10-Q · filed 2022-08-12 | $267.50K 10-Q · filed 2022-08-12 | -$901.65K derived: sum of 3 quarters · filed 2023-03-30 | -$985.43K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | $520.93K 10-Q · filed 2022-05-16 | -$648.22K derived: sum of 2 quarters · filed 2023-03-30 | -$732.00K derived: sum of 3 quarters · filed 2023-03-30 | -$2.62M derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.25M derived: sum of 2 quarters · filed 2023-03-30 | -$3.14M derived: sum of 3 quarters · filed 2023-03-30 | -$667.60K 10-K · filed 2023-03-30 |
| 2020-09-30 | -$83.78K 10-Q · filed 2021-11-08 | -$1.97M derived: sum of 2 quarters · filed 2021-11-08 | $501.54K 10-Q · filed 2021-11-08 | -$591.44K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$1.89M 10-Q · filed 2021-08-12 | $585.32K 10-Q · filed 2021-08-12 | -$507.66K derived: sum of 3 quarters · filed 2022-03-15 | $461.28K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $2.47M 10-Q · filed 2021-05-06 | $1.38M derived: sum of 2 quarters · filed 2022-03-15 | $2.35M derived: sum of 3 quarters · filed 2022-03-15 | $3.02M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$124.04K derived: sum of 2 quarters · filed 2022-03-15 | $551.92K derived: sum of 3 quarters · filed 2022-03-15 | $1.48M 10-K · filed 2022-03-15 |
| 2019-09-30 | $968.94K 10-Q · filed 2020-11-06 | $1.64M derived: sum of 2 quarters · filed 2020-11-06 | $2.58M 10-Q · filed 2020-11-06 | $2.80M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $675.97K 10-Q · filed 2020-08-11 | $1.61M 10-Q · filed 2020-08-11 | $1.83M derived: sum of 3 quarters · filed 2021-03-16 | $1.62M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $932.57K 10-Q · filed 2020-05-15 | $1.15M derived: sum of 2 quarters · filed 2021-03-16 | $944.73K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2018-12-31 | $219.70K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $12.16K derived: sum of 2 quarters · filed 2021-03-16 | $961.13K 10-K · filed 2021-03-16 | |
| 2018-09-30 | -$207.54K 10-Q · filed 2019-11-14 | $741.43K 10-Q · filed 2019-11-14 | ||
| 2017-12-31 | $662.13K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |